Source: Frontiers in medicine. Unidade: FM
Subjects: COVID-19, BIOMARCADORES
ABNT
ALBERCA, Ricardo Wesley et al. Frequencies of CD33+CD11b+HLA-DR-CD14-CD66b+and CD33+CD11b+HLA-DR-CD14+CD66b-Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19. Frontiers in medicine, v. 7, 2020Tradução . . Disponível em: https://doi.org/10.3389/fmed.2020.580677. Acesso em: 02 maio 2024.APA
Alberca, R. W., Andrade, M. M. de S., Branco, A. C. C. C., Pietrobon, A. J., Pereira, N. Z., Fernandes, I. G., et al. (2020). Frequencies of CD33+CD11b+HLA-DR-CD14-CD66b+and CD33+CD11b+HLA-DR-CD14+CD66b-Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19. Frontiers in medicine, 7. doi:10.3389/fmed.2020.580677NLM
Alberca RW, Andrade MM de S, Branco ACCC, Pietrobon AJ, Pereira NZ, Fernandes IG, Oliveira L de M, Aoki V, Duarte AJ da S, Sato MN. Frequencies of CD33+CD11b+HLA-DR-CD14-CD66b+and CD33+CD11b+HLA-DR-CD14+CD66b-Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19 [Internet]. Frontiers in medicine. 2020 ; 7[citado 2024 maio 02 ] Available from: https://doi.org/10.3389/fmed.2020.580677Vancouver
Alberca RW, Andrade MM de S, Branco ACCC, Pietrobon AJ, Pereira NZ, Fernandes IG, Oliveira L de M, Aoki V, Duarte AJ da S, Sato MN. Frequencies of CD33+CD11b+HLA-DR-CD14-CD66b+and CD33+CD11b+HLA-DR-CD14+CD66b-Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19 [Internet]. Frontiers in medicine. 2020 ; 7[citado 2024 maio 02 ] Available from: https://doi.org/10.3389/fmed.2020.580677